Acute laryngeal infections, or disease entities from the circle of croup in children (update)
Article Sidebar
Published:
Jun 30, 2018
Keywords:
acute laryngitis, croup syndrome, children, glucorticosteroids, budezonide, nebulization
Main Article Content
Abstract
The nomenclature of disease entities from the group of croup in children is discussed. Attention was paid to the diagnosis and management of their symptoms. Particular emphasis was placed on the registration conditions of glucocorticosteroids in nebulization (budesonide)
Downloads
Download data is not yet available.
Article Details
How to Cite
Emeryk , A. (2018). Acute laryngeal infections, or disease entities from the circle of croup in children (update). Alergoprofil, 14(2), 45-49. https://doi.org/10.24292/01.AP.214290618
Issue
Section
Article
Copyright: © Medical Education sp. z o.o. This is an Open Access article distributed under the terms of the Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). License (https://creativecommons.org/licenses/by-nc/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Address reprint requests to: Medical Education, Marcin Kuźma (marcin.kuzma@mededu.pl)
References
1. Cherry J.D.: Clinical practice. Croup. N. Engl. J. Med. 2008, 358: 384-391.
2. Zoorob R., Sidani M., Murray J.: Croup: an overview. Am. Fam. Physician 2011, 83: 1067-1073.
3. Fitzgerald D.A.: The assessment and management of croup. Ped. Respir. Rev. 2006, 7: 73-81.
4. Denny F., Murphy T., Clyde W. et al.: Croup: an 11-year study in a pediatric practice. Pediatrics 1983, 71: 871-876.
5. Taussig L.M., Landau L.I., Le Souef P. et al. (red.): Pediatric Respiratory Medicine. Second Edition. Mosby-Elsevier, Philadelphia 2008: 471-477.
6. Rudnik J., Hanicka M. (red.): Ostre przewlekłe choroby układu oddechowego u dzieci. PZWL, Warszawa 1987: 210-247.
7. Kawalec W., Grenda R., Ziółkowska H. et al. (red.): Pediatria, t. II. Wydawnictwo Lekarskie PZWL, Warszawa 2013: 1134-1136.
8. [online: http://www.who.int/classifications/icd/en/ – pobrano14.11.2017 r.].
9. Petrocheilou A., Tanou K., Kalampouka E. et al.: Viral croup: diagnosis and a treatment algorithm. Ped. Pulmonol. 2014, 49: 421-429.
10. Bjornson C.L., Johnson D.W.: Croup. Lancet 2008, 371: 329-339.
11. Rajapaksa S., Starr M.: Croup – assessment and management. Aust. Fam. Physician 2010, 39: 278-182.
12. Rankin I., Wang S.M., Waters A. et al.: The management of recurrent croup in children. J. Laryngol. Otol. 2013, 127: 494-500.
13. Westley C.R., Cotton E.K., Brooks J.G.: Nebulized racemic epinephrine by IPPB for the treatment of croup: a doubl-blind study. Am. J. Dis. Child 1978, 132: 484-487.
14. Mazurek H., Mazurek E.: Zespół krupu w przebiegu zakażenia wirusowego dróg oddechowych. Terapia 2012, 12: 67-71.
15. Dobrovoljac M., Geelhoed G.C.: How fast does oral dexamethasone work in mild to moderately severe croup?A randomized double-blinded clinical trial. Emerg. Med. Austral. 2012, 24: 79-85.
16. Fitzgerald D.A., Kilham H.A.: Croup: assessment and evidenced based management. Med. J. Aust. 2003, 179: 372-377.
17. Bjornson C., Russell K., Vandermeer B. et al.: Nebulized epinephrine for croup in children. Cochrane Database Syst. Rev. 2013, 10: CD006619. DOI: 10.1002/14651858.CD006619.pub3.
18. Russell K.F., Liang Y., O’Gorman K. et al.: Glucocorticoids for croup. Cochrane Database Syst. Rev. 2011, (1): CD001955. DOI: 10.1002/14651858.CD001955.pub3.
19. Moraa I., Sturman N., McGuire T.: Heliox for croup in children Cochrane Database Syst. Rev. 2013, 12: CD006822. DOI: 10.1002/14651858.CD006822.pub4.
20. Tan A.K., Manoukian J.J.: Hospitalized croup (bacterial and viral):the role of rigid endoscopy. J. Otolaryngol. 1992, 21: 48-53.
21. Sendi K., Crysdale W., Yoo J.: Tracheitis: outcome of 1700 cases presenting to the emergency department during two years. J. Otolaryngol. 1992, 21: 20-24.
22. Bjornson C.J., Johnson D.W.: Croup in children. CMAJ 2013, 185: 1317-1323.
23. Gates A., Gates M., Vandermeer B. et al.: Glucocorticoids for croup in children. Cochrane Database Syst. Rev. 2018; 8: CD001955. DOI: 10.1002/14651858.CD001955.pub4.
24. Charakterystyka Produktu Leczniczego Nebbud 0,25 mg/2 ml – zawiesina do nebulizacji 20 amp. Zatwierdzono dnia 26.05.2014 r.
25. Charakterystyka Produktu Leczniczego Nebbud 0,5 mg/1 ml – zawiesina do nebulizacji 20 amp. Zatwierdzono dnia 18.08.2014 r.
26. [online: https://www.doz.pl/apteka/p109836Nebbud_0125_mgml_zawiesina_do_nebulizacji_20_ampulek_x_2_ml].
27. [online: http://leki.urpl.gov.pl/files/34_Budixon_Neb_zawiesina_do_nebulizacji_0_125mg_ml_0_25mg_ml_0_5mg_ml.pdf].
28. [online: http://docplayer.pl/7852248-Charakterystyka-produktu-leczniczego.html].
29. [online: http://leki.urpl.gov.pl/files/40_Benodil_zaw.pdf].
2. Zoorob R., Sidani M., Murray J.: Croup: an overview. Am. Fam. Physician 2011, 83: 1067-1073.
3. Fitzgerald D.A.: The assessment and management of croup. Ped. Respir. Rev. 2006, 7: 73-81.
4. Denny F., Murphy T., Clyde W. et al.: Croup: an 11-year study in a pediatric practice. Pediatrics 1983, 71: 871-876.
5. Taussig L.M., Landau L.I., Le Souef P. et al. (red.): Pediatric Respiratory Medicine. Second Edition. Mosby-Elsevier, Philadelphia 2008: 471-477.
6. Rudnik J., Hanicka M. (red.): Ostre przewlekłe choroby układu oddechowego u dzieci. PZWL, Warszawa 1987: 210-247.
7. Kawalec W., Grenda R., Ziółkowska H. et al. (red.): Pediatria, t. II. Wydawnictwo Lekarskie PZWL, Warszawa 2013: 1134-1136.
8. [online: http://www.who.int/classifications/icd/en/ – pobrano14.11.2017 r.].
9. Petrocheilou A., Tanou K., Kalampouka E. et al.: Viral croup: diagnosis and a treatment algorithm. Ped. Pulmonol. 2014, 49: 421-429.
10. Bjornson C.L., Johnson D.W.: Croup. Lancet 2008, 371: 329-339.
11. Rajapaksa S., Starr M.: Croup – assessment and management. Aust. Fam. Physician 2010, 39: 278-182.
12. Rankin I., Wang S.M., Waters A. et al.: The management of recurrent croup in children. J. Laryngol. Otol. 2013, 127: 494-500.
13. Westley C.R., Cotton E.K., Brooks J.G.: Nebulized racemic epinephrine by IPPB for the treatment of croup: a doubl-blind study. Am. J. Dis. Child 1978, 132: 484-487.
14. Mazurek H., Mazurek E.: Zespół krupu w przebiegu zakażenia wirusowego dróg oddechowych. Terapia 2012, 12: 67-71.
15. Dobrovoljac M., Geelhoed G.C.: How fast does oral dexamethasone work in mild to moderately severe croup?A randomized double-blinded clinical trial. Emerg. Med. Austral. 2012, 24: 79-85.
16. Fitzgerald D.A., Kilham H.A.: Croup: assessment and evidenced based management. Med. J. Aust. 2003, 179: 372-377.
17. Bjornson C., Russell K., Vandermeer B. et al.: Nebulized epinephrine for croup in children. Cochrane Database Syst. Rev. 2013, 10: CD006619. DOI: 10.1002/14651858.CD006619.pub3.
18. Russell K.F., Liang Y., O’Gorman K. et al.: Glucocorticoids for croup. Cochrane Database Syst. Rev. 2011, (1): CD001955. DOI: 10.1002/14651858.CD001955.pub3.
19. Moraa I., Sturman N., McGuire T.: Heliox for croup in children Cochrane Database Syst. Rev. 2013, 12: CD006822. DOI: 10.1002/14651858.CD006822.pub4.
20. Tan A.K., Manoukian J.J.: Hospitalized croup (bacterial and viral):the role of rigid endoscopy. J. Otolaryngol. 1992, 21: 48-53.
21. Sendi K., Crysdale W., Yoo J.: Tracheitis: outcome of 1700 cases presenting to the emergency department during two years. J. Otolaryngol. 1992, 21: 20-24.
22. Bjornson C.J., Johnson D.W.: Croup in children. CMAJ 2013, 185: 1317-1323.
23. Gates A., Gates M., Vandermeer B. et al.: Glucocorticoids for croup in children. Cochrane Database Syst. Rev. 2018; 8: CD001955. DOI: 10.1002/14651858.CD001955.pub4.
24. Charakterystyka Produktu Leczniczego Nebbud 0,25 mg/2 ml – zawiesina do nebulizacji 20 amp. Zatwierdzono dnia 26.05.2014 r.
25. Charakterystyka Produktu Leczniczego Nebbud 0,5 mg/1 ml – zawiesina do nebulizacji 20 amp. Zatwierdzono dnia 18.08.2014 r.
26. [online: https://www.doz.pl/apteka/p109836Nebbud_0125_mgml_zawiesina_do_nebulizacji_20_ampulek_x_2_ml].
27. [online: http://leki.urpl.gov.pl/files/34_Budixon_Neb_zawiesina_do_nebulizacji_0_125mg_ml_0_25mg_ml_0_5mg_ml.pdf].
28. [online: http://docplayer.pl/7852248-Charakterystyka-produktu-leczniczego.html].
29. [online: http://leki.urpl.gov.pl/files/40_Benodil_zaw.pdf].